231 related articles for article (PubMed ID: 2941085)
21. A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas.
Kamoun M; Kadin ME; Martin PJ; Nettleton J; Hansen JA
J Immunol; 1981 Sep; 127(3):987-91. PubMed ID: 6790625
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
Han T; Ozer H; Minowada J
Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
[TBL] [Abstract][Full Text] [Related]
23. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.
Royston I; Majda JA; Baird SM; Meserve BL; Griffiths JC
J Immunol; 1980 Aug; 125(2):725-31. PubMed ID: 6993560
[TBL] [Abstract][Full Text] [Related]
24. B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cells.
Mulligan SP; Travade P; Matutes E; Dearden C; Visser L; Poppema S; Catovsky D
Blood; 1990 Sep; 76(5):959-64. PubMed ID: 2118401
[TBL] [Abstract][Full Text] [Related]
25. Characterization of B-cell type chronic lymphocytic leukemia cells by surface markers and a monoclonal antibody.
Koziner B; Gebhard D; Denny T; Evans RL
Am J Med; 1982 Dec; 73(6):802-7. PubMed ID: 6756136
[TBL] [Abstract][Full Text] [Related]
26. Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.
Guy K; Krajewski AS; Dewar AE
Br J Cancer; 1986 Feb; 53(2):161-73. PubMed ID: 3513812
[TBL] [Abstract][Full Text] [Related]
27. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.
Hanson CA; Gribbin TE; Schnitzer B; Schlegelmilch JA; Mitchell BS; Stoolman LM
Blood; 1990 Dec; 76(11):2360-7. PubMed ID: 1701669
[TBL] [Abstract][Full Text] [Related]
28. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
29. Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells.
Boumsell L; Bernard A; Lepage V; Degos L; Lemerle J; Dausset J
Eur J Immunol; 1978 Dec; 8(12):900-4. PubMed ID: 83236
[TBL] [Abstract][Full Text] [Related]
30. Immunopathology of non-Hodgkin lymphomas.
Huber H; Gattringer C; Knapp W; Stein H
Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
[TBL] [Abstract][Full Text] [Related]
31. Immunologic classification of lymphocytic leukemias based on monoclonal antibody-defined cell surface antigens.
Schroff RW; Foon KA; Billing RJ; Fahey JL
Blood; 1982 Feb; 59(2):207-15. PubMed ID: 7034809
[TBL] [Abstract][Full Text] [Related]
32. Rabbit antisera to cell lines RC2a and U937: antigens expressed on human leukaemic cells of myeloid, monocyte and T-lymphocyte lineage.
Pilkington G; Jacobs D; Mackenzie S; Bradley R; Hunter S; Jose D
Aust J Exp Biol Med Sci; 1982 Oct; 60 (Pt 5)():479-92. PubMed ID: 6819843
[TBL] [Abstract][Full Text] [Related]
33. The common acute lymphoid leukemia antigen on b cells of chronic lymphoid leukemia and non-Hodgkin's lymphoma.
Canon C; Augier C; Reizenstein P; Goutner A; de Vassal F; Mathé G
Biomed Pharmacother; 1983; 37(2):90-2. PubMed ID: 6604552
[TBL] [Abstract][Full Text] [Related]
34. Discrepancy between phenotypic and functional features of natural killer T-lymphocytes in B-cell chronic lymphocytic leukaemia.
Foa R; Lauria F; Lusso P; Giubellino MC; Fierro MT; Ferrando ML; Raspadori D; Matera L
Br J Haematol; 1984 Nov; 58(3):509-16. PubMed ID: 6333890
[TBL] [Abstract][Full Text] [Related]
35. Establishment and characterization of leukemic T-cell lines, B-cell lines, and null-cell line: a progress report on surface antigen study of fresh lymphatic leukemias in man.
Minowada J; Tsubota T; Nakazawa S; Srivastava BI; Huang CC; Oshimura M; Sonta S; Han T; Sinks LF; Sandberg AA
Haematol Blood Transfus; 1977; 20():241-51. PubMed ID: 305398
[TBL] [Abstract][Full Text] [Related]
36. The chronic lymphocytic leukemia antigen (cCLLa) as immunotherapy target: assessment of LD50 and MTD of four ricin-based anti-cCLLa immunotoxins (ITs) in Balb/c mice.
Faguet GB; Agee JF
Leuk Lymphoma; 1997 May; 25(5-6):531-7. PubMed ID: 9250824
[TBL] [Abstract][Full Text] [Related]
37. [Morphologic and immunologic criteria for the diagnosis of non-Hodgkin's lymphoma of low-grade malignancy].
Odermatt BF; Maurer R; Rüttner JR
Schweiz Rundsch Med Prax; 1986 Apr; 75(15):401-7. PubMed ID: 3485809
[No Abstract] [Full Text] [Related]
38. A monoclonal antibody detecting a 39,000 m.w. molecule that is present on B lymphocytes and chronic lymphocytic leukemia cells but is rare on acute lymphocytic leukemia blasts.
Zipf TF; Lauzon GJ; Longenecker BM
J Immunol; 1983 Dec; 131(6):3064-72. PubMed ID: 6358359
[TBL] [Abstract][Full Text] [Related]
39. An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. Distribution on normal and malignant lymphoid cells.
Boumsell L; Coppin H; Pham D; Raynal B; Lemerle J; Dausset J; Bernard A
J Exp Med; 1980 Jul; 152(1):229-34. PubMed ID: 6967511
[TBL] [Abstract][Full Text] [Related]
40. The value of the monoclonal antibody, DBA44, in the diagnosis of B-lymphoid disorders.
Salomon-Nguyen F; Valensi F; Troussard X; Flandrin G
Leuk Res; 1996; 20(11-12):909-13. PubMed ID: 9009248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]